Identification of a potent serum factor that causes desensitization of the receptor for C-type natriuretic peptide

Cell Communication and Signaling

Volumn 1, Issue , 2003, Pages

  Chrisman, Ted D ^a,c   Perkins, Dorenda T ^a,c   Garbers, David L ^a,b,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIETHYLAMINOETHANOL; APOLIPOPROTEIN A2; BUTANOL; GROWTH FACTOR; GUANYLATE CYCLASE; HIGH DENSITY LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NATRIURETIC PEPTIDE TYPE C; PERTUSSIS TOXIN; PROTEIN KINASE B; SEPHAROSE; SOLVENT; SPHINGOSINE 1 PHOSPHATE; SPHINGOSYLPHOSPHORYLCHOLINE; THROMBOCYTE ACTIVATING FACTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACTION; LIPID TRANSPORT; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVERSED PHASE LIQUID CHROMATOGRAPHY; SERUM FACTOR; SIGNAL TRANSDUCTION; TISSUE INJURY;

BOS TAURUS;

EID: 19444371887     PISSN: 1478811X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-811X-1-4     Document Type: Article

References (23)

1. Chrisman TD, Garbers DL: Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts. J Biol Chem 1999, 274:4293-4299.
2. Ueno H, Haruno A, Morisaki N, Furuya M, Kangawa K, Takeshita A, Saito Y: Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/ paracrine loop. Circulation 1997, 96:2272-2279.
3. Tamura N, Chrisman TD, Garbers DL: The regulation and physiological roles of the guanylyl cyclase receptors. Endocr J 2001, 48:611-634.
4. Abbey SE, Potter LR: Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-8. Endocrinology 2003, 144:240-246.
5. Horio T, Tokudome T, Maki T, Yoshihara F, Suga S, Nishikimi T, Kojima M, Kawano Y, Kangawa K: Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 2003, 144:2279-2284.
6. Cao L, Gardner DG: Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 1995, 25:227-234.
7. Potter LR, Garbers DL: Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. J Biol Chem 1992, 267:14531-14534.
8. Potter LR: Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization. Biochemistry 1998, 37:2422-2429.
9. Motizuki M, Itoh T, Yamada M, Shimamura S, Tsurugi K: Purification, primary structure, and antimicrobial activities of bovine apolipoprotein A-11. J Biochem (Tokyo) 1998, 123:675-679.
10. Mahley RW, Innerarity TL, Rall SC Jr., Weisgraber KH: Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984, 25:1277-1294.
11. Swaney JB: Characterization of the high-density lipoprotein and its major apoprotein from human, canine, bovine and chicken plasma. Biochim Biophys Acta 1980, 617:489-502.
12. Sachinidis A, Kettenhofen R, Seewald S, Gouni-Berthold I, Schmitz U, Seul C, Ko Y, Vetter H: Evidence that lipoproteins are carriers of bioactive factors. Arterioscler Thromb Vasc Biol 1999, 19:2412-2421.
13. Okajima F: Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 2002, 1582:132-137.
14. Moolenaar WH: Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 1995, 270:12949-12952.
15. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG: Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. Faseb J 2000, 14:2255-2265.
16. Watterson K, Sankala H, Milstien S, Spiegel S: Pleiotropic actions of sphingosine-1-phosphate. Prog Lipid Res 2003, 42:344-357.
17. Van Brocklyn JR, Lee MJ, Menzeleev R, Olivera A, Edsall L, Cuvillier O, Thomas DM, Coopman PJ, Thangada S, Liu CH, Hla T, Spiegel S: Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-I and intracellular to regulate proliferation and survival. J Cell Biol 1998, 142:229-240.
18. Maceyka M, Payne SG, Milstien S, Spiegel S: Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 2002, 1585:193-201.
19. Goetzl EJ, An S: Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. Faseb J 1998, 12:1589-1598.
20. Burnstock G: Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002, 22:364-373.
21. Payne SG, Milstien S, Spiegel S: Sphingosine-1-phosphate: dual messenger functions. FEBS Lett 2002, 531:54-57.
22. Chrisman TD, Schulz S, Potter LR, Garbers DL: Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides. J Biol Chem 1993, 268:3698-3703.
23. Havel RJ, Eder HA, Bragton JH: The distribution and chemical composition of ultracentrifugally seperated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.